Antibody Engineering & Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Michael Weiner
VP, Molecular Sciences at AxioMx, an Abcam Company

Profile

Michael Weiner, Ph.D., V.P. Molecular Sciences and Global Head of Research, Abcam. Having founded more than 4 biotech companies, Dr Weiner is a serial scientist-entrepreneur. He has invented and/or helped to develop commonly used molecular biology tools and technologies, including the first to sequence M.BamHI, the QuikChange Mutagenesis kit, DNA bar-coding of Luminex beads, Emulsion PCR, Digital PCR, microfluidic droplet labeling, and the first commercial Next Generation DNA sequencing instrument. His more recent work has focused on proteomics, antibody discovery, and antibody engineering.

Michael Weiner's Network

Agenda Sessions

  • Targeting Antibody Discovery Using Directed Phospho Antibody-clonotype (DPAC)

    ,